-
WEHI-539: A Selective BCL-XL Inhibitor Workflow
2026-08-30
WEHI-539 provides a mechanistically focused way to test whether cell survival depends on BCL-XL rather than applying a nonspecific cytotoxic challenge. This guide connects apoptosis assays, MCL-1 interaction studies, glioblastoma models, and cancer stem cell sensitization with practical workflow and troubleshooting advice.
-
Cisplatin Beyond Cytotoxicity: A Renal Toxicity Lens
2026-08-29
Cisplatin is more than a DNA-damaging anticancer tool: its renal effects can reveal how acute injury progresses toward inflammation and fibrosis. This guide integrates CDDP chemistry, assay design, and SMYD2-based mechanistic insights for more informative cancer research.
-
PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress
2026-08-28
The reference study links perfluorooctane sulfonate exposure to human kidney tubular-cell injury through coordinated ferroptosis and endoplasmic reticulum stress responses. Its integrated biomarker strategy provides a mechanistic framework for studying PFOS nephrotoxicity and evaluating pathway-directed interventions.
-
Lanabecestat (AZD3293) in BACE1 Research
2026-08-28
Lanabecestat (AZD3293) enables controlled BACE1 enzyme inhibition in neuronal models, helping researchers connect amyloid-beta production inhibition with functional synaptic measurements. This workflow-focused guide shows how to model partial inhibition, preserve assay interpretability, and troubleshoot discordant amyloid and electrophysiology results.
-
Staurosporine Beyond Apoptosis: A Translational Lens
2026-08-27
Staurosporine is more than a canonical apoptosis tool: its broad kinase activity can reveal how impending cell death reshapes tumor-cell behavior, ER stress, cytokine signaling, and angiogenic potential. This article outlines a translational workflow for using Staurosporine to distinguish cytotoxicity from prometastatic survivor-state biology.
-
Necrostatin 2 (Nec-2) Assay Workflows
2026-08-27
Necrostatin 2 (Nec-2) provides a temporally controllable way to test RIPK2-linked cell-death signaling alongside membrane-repair and inflammatory readouts. This guide translates findings from Kupffer-cell Listeria research into practical assay design, concentration scouting, controls, and troubleshooting for necroptosis inhibition and ischemic stroke research.
-
Spinosad, CHRNA5, and EGFR Signaling in LUAD
2026-08-26
A 2024 study identifies spinosad as an inhibitor of lung adenocarcinoma proliferation and connects its activity to disruption of the CHRNA5–EGFR signaling axis. Transcriptomic, protein-interaction, cellular, and animal experiments suggest a mechanism involving G1 arrest, apoptosis, and improved response to gefitinib.
-
β-Elemene: Mechanisms and Research Workflows
2026-08-26
β-Elemene, also called Levo-β-elemene in some research contexts, is a C15H24 sesquiterpene studied in apoptosis, metabolism, neuroprotection, and inflammation. Primary cell evidence shows that β-elemene can inhibit MDI-induced adipogenesis in 3T3-L1 cells while influencing AMPK signaling, but these findings remain model- and concentration-dependent.
-
Fasudil (HA-1077) HCl: ROCK Workflow Guide
2026-08-25
Build reproducible ROCK-pathway experiments with Fasudil (HA-1077) HCl across cancer, migration, apoptosis, and pathway-crosstalk models. This practical guide connects dose design, orthogonal readouts, and Hippo-pathway assay logic while separating established evidence from testable extensions.
-
Kidney Progenitor Assembloids Model Renal Disease
2026-08-25
Huang and colleagues developed spatially patterned mouse and human kidney progenitor assembloids that recreate key self-assembly events between nephron and collecting-system progenitors. The resulting models improve cellular organization, maturation, function, and modeling of PKD2-associated polycystic kidney disease compared with conventional kidney organoids.
-
Engineered Klotho mRNA Reverses iMSC Senescence
2026-08-24
This study developed an ARCA-capped, pseudouridine-modified, polyadenylated Klotho mRNA and delivered it with hyperbranched poly(β-amino ester)s to senescent and Klotho-deficient induced mesenchymal stem cells. A single treatment restored Klotho expression and improved senescence-associated, mitochondrial, oxidative-stress, and calcium-homeostasis phenotypes, while producing little effect in young cells.
-
Mouse Interleukin-12 mRNA: Delivery Logic
2026-08-24
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) combines Cap 1, m1Ψ, and a poly(A) tail for interpretable cytokine expression studies. This guide focuses on matching mRNA chemistry, delivery vehicles, and immune-function readouts rather than treating cargo and formulation as separate decisions.
-
Trichostatin A (TSA): Applied Research Workflows
2026-08-23
Build reproducible HDAC inhibition experiments with Trichostatin A (TSA), from solvent handling and dose–time design to histone acetylation, proliferation, and differentiation readouts. A practical bridge to the AMC-Hem HO-1 probe study shows how TSA perturbation can be paired with live-cell enzyme-activity imaging without overstating cross-domain evidence.
-
DDX3 Helicase Domain: Expression and X-ray Analysis
2026-08-22
Rodamilans and Montoya established a reproducible route to a crystallizable C-terminal helicase domain of human DDX3, a disease-relevant DEAD-box RNA helicase. The resulting P21 crystals diffracted to 2.2 Å, providing an important structural platform for investigating RNA recognition, ATP-coupled conformational change, and future inhibitor design.
-
Antiseptics for Burns: Evidence and Research Implications
2026-08-22
The Cochrane review assessed whether topical antiseptics and antiseptic-containing dressings improve healing or reduce infection in burn wounds. Its central contribution was a structured comparison of multiple topical strategies, but substantial uncertainty and heterogeneity limited conclusions about superiority, safety, and optimal use.